CN219208433U - Novel blood bag for trioxytherapy - Google Patents
Novel blood bag for trioxytherapy Download PDFInfo
- Publication number
- CN219208433U CN219208433U CN202223016023.0U CN202223016023U CN219208433U CN 219208433 U CN219208433 U CN 219208433U CN 202223016023 U CN202223016023 U CN 202223016023U CN 219208433 U CN219208433 U CN 219208433U
- Authority
- CN
- China
- Prior art keywords
- ozone
- blood
- membrane body
- pipeline
- blood bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model provides a novel blood bag for trioxytherapy, which comprises a blood bag; one end of the blood collection pipeline is communicated with the blood bag, and the other end of the blood collection pipeline is connected with the hemostix; one end of the ozone pipeline is communicated with the blood bag, and the other end of the ozone pipeline is connected with an ozone generator; one end of the liquid filling pipe is communicated with the blood bag; the ozone device comprises an ozone pipeline, a first membrane body and a second membrane body, wherein the first membrane body and the second membrane body are arranged in the ozone pipeline and close to the blood bag, the second membrane body is located at the upstream of the first membrane body, the first membrane body is of a breathable and hydrophobic structure, and the second membrane body is of an easy-tearing structure. The novel trioxygen treatment blood bag provided by the utility model can be used for simultaneously storing blood and injecting ozone to achieve a treatment effect, and can be used for avoiding the problem of blood backflow during ozone injection.
Description
Technical Field
The utility model relates to the technical field of medical supplies, in particular to a novel blood bag for trioxytherapy.
Background
The novel trioxygen treatment blood bag in the current market is generally designed for an ozone connecting pipeline with a blocking device matched with the blood bag, the whole trioxygen treatment process can be completed through the design, but an operator is required to actively lock the pipeline by using a clamping piece after the trioxygen infusion is completed, and more blood is inevitably remained in one pipeline.
Disclosure of Invention
The present utility model aims to solve at least one of the technical problems existing in the prior art.
Therefore, the utility model provides a novel blood bag for trioxytherapy.
The utility model provides a novel blood bag for trioxytherapy, which comprises:
a blood bag;
one end of the blood collection pipeline is communicated with the blood bag, and the other end of the blood collection pipeline is connected with the hemostix;
one end of the ozone pipeline is communicated with the blood bag, and the other end of the ozone pipeline is connected with an ozone generator;
one end of the liquid filling pipe is communicated with the blood bag;
the ozone device comprises an ozone pipeline, a first membrane body and a second membrane body, wherein the first membrane body and the second membrane body are arranged in the ozone pipeline and close to the blood bag, the second membrane body is located at the upstream of the first membrane body, the first membrane body is of a breathable and hydrophobic structure, and the second membrane body is of an easy-tearing structure.
The utility model provides a novel trioxygen therapy blood bag, which comprises a blood bag, a blood sampling pipeline, an ozone pipeline and a fluid supplementing pipe. Three pipe orifices are formed at the bottom of the blood bag for connecting the blood sampling pipeline, the ozone pipeline and the fluid supplementing pipe. Wherein, the other end of the blood sampling pipeline is used for connecting a hemostix, and the blood of a patient enters into the blood bag through the blood sampling pipeline. The other end of the ozone pipeline is used for being connected with an ozone generator, and ozone is injected into the blood bag through the ozone pipeline so as to complete the process of mixing with blood. The fluid infusion tube is used for infusing therapeutic agent such as liquid medicine. On the basis, in order to further solve the problems in the prior art, the first membrane body and the second membrane body are added at the connection position of the ozone pipeline and the blood collection bag. The first membrane body is of a breathable and hydrophobic structure, namely, the first membrane body only allows ozone to pass through and prevents blood from penetrating, and the first membrane body is breathable, water-blocking and bacteria-blocking. Therefore, when ensuring that ozone can smoothly enter the blood bag, the blood can be prevented from flowing back to the ozone pipeline, so that the waste of the blood is caused. In addition, the second membrane body is added at the upstream of the first membrane body, when ozone is injected into the blood bag, the ozone passes through the first membrane body at first and directly contacts with the second membrane body, and after the pressure of the ozone reaches a certain degree, the second membrane body is torn or separated from the wall of the blood bag to form an ozone passage, so that the ozone is ensured to enter the blood bag. In addition, the second membrane body can prevent blood from contacting with the first membrane body before ozone is introduced, so that poor ventilation after the first membrane body contacts with high-viscosity blood is avoided. It should be noted that the second film body may be a film structure so as to realize the characteristic of easy tearing of the second film body, and the second film body is in a state of being adhered to the pipe wall so as to realize easy detachment of the second film body. Therefore, the novel trioxygen treatment blood bag provided by the use can be used for avoiding the problem of blood backflow during the injection of ozone while meeting the requirements of blood bag for storing blood and injecting ozone to achieve a treatment effect.
The novel trioxytherapy blood bag according to the technical scheme of the utility model can also have the following additional technical characteristics:
in the above technical solution, the first membrane body is a breathable hydrophobic membrane, so as to allow ozone to pass through and enter the blood bag and prevent blood from penetrating and penetrating into the blood collection pipeline.
In this technical solution, the first film body is further defined. The first membrane body adopts a breathable hydrophobic membrane, so that ozone can smoothly pass through the first membrane body and enter the blood bag. And preventing blood from penetrating into the ozone pipeline from the first membrane body, thereby avoiding the problem of blood waste caused by blood backflow.
In the above technical solution, a gas space is formed between the first membrane body and the second membrane body, and ozone passes through the first membrane body and fills in the gas space, so that the second membrane body is finally torn or separated from the pipe wall, thereby forming a passage of the ozone pipeline.
In this technical scheme, because there is certain interval first membrane body and second membrane body, consequently formed the gas space, this space is used for holding the ozone through first membrane body, when the ozone accumulated to certain pressure in the gas space, the second membrane body reached limit expansion state, and then caused self tearing, allowed ozone to pass through the second membrane body. Or the bonding state of the second membrane body and the tube wall is invalid, and the second membrane body is separated from the tube wall, so that a passage of ozone is formed, and the ozone is allowed to enter the blood bag. The process does not need manual intervention or operation, and realizes the rapid and convenient ozone injection process.
In the above technical scheme, the other end of the ozone pipeline is provided with a first easy-to-connect piece, and the first easy-to-connect piece and the pipeline of the ozone generator form detachable connection.
In this technical scheme, be provided with first easy connecting piece at the other end of ozone pipeline, first easy connecting piece and ozone generator's pipeline form detachable connected mode, the connection and the dismantlement of the ozone pipeline of being convenient for. Specifically, the first easy-to-connect member may be in the form of a pipe hoop, and is tightly sleeved with the pipeline of the ozone generator, so as to achieve quick and convenient connection.
In the above technical scheme, the other end of the blood sampling pipeline is provided with a second easy-to-connect piece, and the second easy-to-connect piece and the blood sampling device form detachable connection.
In this technical scheme, be provided with the easy connecting piece of second at the other end of blood sampling pipeline, the port of the easy connecting piece of second and hemostix forms detachable connected mode, the connection and the dismantlement of the blood sampling pipeline of being convenient for. Specifically, the second easy-to-connect member may be in the form of a pipe hoop, and is tightly sleeved with the port of the hemostix, thereby realizing quick and convenient connection.
In the above technical scheme, a blocking device is arranged in the blood sampling pipeline.
In the technical scheme, a blocking device is arranged in the blood sampling pipeline. When the device is used, the blocking device is broken off, so that the passage of the blood sampling pipeline can be realized, and the blood sampling process can be further carried out. It should be noted that the structure of the blocking device and the principle of use thereof are well known in the art (see page 8 of GB 14232.4-2021 for a description of the device), and therefore will not be described in detail.
Additional aspects and advantages of the utility model will be set forth in part in the description which follows, or may be learned by practice of the utility model.
Drawings
The foregoing and/or additional aspects and advantages of the utility model will become apparent and may be better understood from the following description of embodiments taken in conjunction with the accompanying drawings in which:
FIG. 1 is a front view of a novel trioxytherapeutic blood bag of the present utility model;
fig. 2 is a partial enlarged view of fig. 1 at a.
The correspondence between the reference numerals and the component names in fig. 1 to 2 is:
1. a first easy-to-connect member; 2. an ozone pipeline; 3. a first film body; 4. a tube wall; 5. a second film body; 6. a blood bag; 7. a second easy-to-connect member; 8. a blocking device; 9. a liquid filling pipe; 10. and a blood sampling pipeline.
Detailed Description
In order that the above-recited objects, features and advantages of the present utility model will be more clearly understood, a more particular description of the utility model will be rendered by reference to the appended drawings and appended detailed description. It should be noted that, in the case of no conflict, the embodiments of the present application and the features in the embodiments may be combined with each other.
In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present utility model, however, the present utility model may be practiced otherwise than as described herein, and therefore the scope of the present utility model is not limited to the specific embodiments disclosed below.
The novel blood bag for trioxytherapy provided according to some embodiments of the present utility model is described below with reference to fig. 1 to 2.
Some embodiments of the present application provide a novel blood bag for trioxytherapy.
As shown in fig. 1 to 2, a first embodiment of the present utility model proposes a novel blood bag for trioxytherapy, comprising:
a blood bag 6;
a blood sampling pipeline 10, one end of which is communicated with the blood bag 6, and the other end of which is used for being connected with a hemostix;
an ozone pipeline 2, one end of which is communicated with the blood bag 6, and the other end of which is connected with an ozone generator;
a liquid filling pipe 9, one end of which is communicated with the blood bag 6;
the ozone device comprises an ozone pipeline 2, a first membrane body 3 and a second membrane body 5, wherein the first membrane body 3 and the second membrane body 5 are arranged in the ozone pipeline 2 and close to a blood bag 6, the second membrane body 5 is located on the upstream of the first membrane body 3, the first membrane body 3 is of a breathable and hydrophobic structure, and the second membrane body 5 is of an easy-tearing structure.
The utility model provides a novel trioxygen therapy blood bag 6, which comprises a blood bag 6, a blood sampling pipeline 10, an ozone pipeline 2 and a fluid supplementing pipe. Three nozzles are formed at the bottom of the blood bag 6 for connection of the blood sampling line 10, the ozone line 2 and the fluid supply line. The other end of the blood collection tube 10 is used for connecting with a hemostix, and blood of a patient enters the blood bag 6 through the blood collection tube 10. The other end of the ozone pipeline 2 is used for being connected with an ozone generator, and ozone is injected into the blood bag 6 through the ozone pipeline 2 so as to complete the process of mixing with blood. The fluid infusion tube is used for infusing therapeutic agent such as liquid medicine. On the basis of the above, in order to further solve the problems existing in the prior art, the first membrane body 3 and the second membrane body 5 are added at the connection position of the ozone pipeline 2 and the blood collection bag 6. The first membrane body 3 has a breathable and hydrophobic structure, namely, the first membrane body 3 only allows ozone to pass through and prevents blood from penetrating, and can be breathable, water-blocking and bacteria-blocking. Therefore, while ensuring that ozone can smoothly enter the blood bag 6, the backflow of blood to the ozone line 2 can be avoided to cause waste of blood. In addition, a second membrane body 5 is added at the upstream of the first membrane body 3, when ozone is injected, the ozone firstly passes through the first membrane body 3 and directly contacts with the second membrane body 5, and when the pressure of the ozone reaches a certain degree, the second membrane body 5 is torn or separated from the tube wall 4 to form an ozone passage, so that the ozone is ensured to enter the blood bag 6. In addition, the second membrane body 5 can prevent the blood from contacting the first membrane body 3 before ozone is introduced, and prevent poor ventilation after the first membrane body 3 contacts the high-viscosity blood. It should be noted that the second film 5 may be a film structure to achieve the characteristic of easy tearing, and the second film 5 is adhered to the pipe wall 4, so as to achieve easy detachment of the second film 5. Therefore, the novel trioxygen treatment blood bag 6 provided by the use of the ozone injection device can simultaneously store blood and inject ozone to achieve a treatment effect, and can also avoid the problem of blood backflow during ozone injection.
The second embodiment of the present utility model proposes a novel blood bag for trioxytherapy, and on the basis of the first embodiment, the first membrane body 3 is a breathable hydrophobic membrane, so as to allow ozone to pass through and enter the blood bag 6 and prevent blood from penetrating and penetrating into the blood collection tube 10.
In the present embodiment, the first film body 3 is further defined. As before, the first membrane body 3 adopts a breathable hydrophobic membrane, so that ozone can smoothly pass through the first membrane body 3 and enter the blood bag 6. And prevents blood from penetrating into the ozone pipeline 2 from the first membrane body 3, thereby avoiding the problem of blood waste caused by blood backflow.
The third embodiment of the present utility model proposes a novel blood bag for trioxytherapy, and based on any of the above embodiments, a gas space is formed between the first membrane body 3 and the second membrane body 5, and ozone passes through the first membrane body 3 and fills the gas space, so that the second membrane body 5 is finally torn or separated from the tube wall 4, so as to form a passage of the ozone pipeline 2.
In this embodiment, since the first membrane body 3 and the second membrane body 5 have a certain distance, a gas space is formed, and this space is used for containing ozone passing through the first membrane body 3, when ozone builds up to a certain pressure in the gas space, the second membrane body 5 reaches a limit expansion state, and then causes tearing of itself, allowing ozone to pass through the second membrane body 5. Alternatively, the adhesion state of the second film body 5 to the tube wall 4 fails, and the second film body 5 is detached from the tube wall 4, thereby forming a passage of ozone, allowing ozone to enter the blood bag 6. The process does not need manual intervention or operation, and realizes the rapid and convenient ozone injection process.
The fourth embodiment of the present utility model provides a novel blood bag for trioxytherapy, and on the basis of any one of the above embodiments, a first easy-to-connect member 1 is disposed at the other end of the ozone pipeline 2, and the first easy-to-connect member 1 and the pipeline of the ozone generator form detachable connection.
In this embodiment, a first easy-to-connect member 1 is disposed at the other end of the ozone pipeline 2, and the first easy-to-connect member 1 and the pipeline of the ozone generator form a detachable connection mode, so that the connection and the detachment of the ozone pipeline 2 are facilitated. Specifically, the first easy-to-connect member 1 may be in the form of a pipe hoop, and is tightly sleeved with the pipeline of the ozone generator, thereby realizing quick and convenient connection.
The fifth embodiment of the present utility model provides a novel blood bag for trioxytherapy, and on the basis of any of the above embodiments, a second easy-to-connect member 7 is disposed at the other end of the blood collection tube 10, and the second easy-to-connect member 7 is detachably connected with the blood collector.
In this embodiment, the second easy-to-connect member 7 is disposed at the other end of the blood sampling tube 10, and the second easy-to-connect member 7 and the port of the blood sampling device form a detachable connection mode, so that the blood sampling tube 10 can be conveniently connected and detached. Specifically, the second easy-to-connect member 7 may be in the form of a pipe hoop, and is tightly sleeved with the port of the hemostix, thereby realizing quick and convenient connection.
The sixth embodiment of the present utility model proposes a new blood bag for trioxytherapy, and on the basis of any of the above embodiments, a blocking device 8 is disposed in the blood collection tube 10.
In the present embodiment, the blocking device 8 is provided in the blood collection tube 10. When in use, the blocking device 8 is broken off, so that the passage of the blood sampling pipeline 10 can be realized, and then the blood sampling process can be carried out.
In this specification, schematic representations of the above terms do not necessarily refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.
Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present utility model should be included in the protection scope of the present utility model.
Claims (6)
1. A novel blood bag for trioxytherapy, comprising:
a blood bag;
one end of the blood collection pipeline is communicated with the blood bag, and the other end of the blood collection pipeline is connected with the hemostix;
one end of the ozone pipeline is communicated with the blood bag, and the other end of the ozone pipeline is connected with an ozone generator;
one end of the liquid filling pipe is communicated with the blood bag;
the ozone device comprises an ozone pipeline, a first membrane body and a second membrane body, wherein the first membrane body and the second membrane body are arranged in the ozone pipeline and close to the blood bag, the second membrane body is located at the upstream of the first membrane body, the first membrane body is of a breathable and hydrophobic structure, and the second membrane body is of an easy-tearing structure.
2. The novel trioxytherapeutic blood bag according to claim 1, wherein the first membrane body is a breathable hydrophobic membrane to allow ozone to pass into the blood bag and to prevent blood from passing through and into the blood collection line.
3. The novel trioxytherapeutic blood bag according to claim 2, wherein a gas space is formed between the first membrane and the second membrane, ozone passes through the first membrane and fills the gas space, and finally the second membrane tears or breaks away from the tube wall to form a passage of the ozone pipeline.
4. The novel blood bag for trioxygen therapy according to claim 3, wherein a first easy-to-connect member is arranged at the other end of the ozone pipeline, and the first easy-to-connect member is detachably connected with the pipeline of the ozone generator.
5. The novel blood bag for trioxytherapy according to claim 4, wherein the other end of the blood collection tube is provided with a second easily-connected member, and the second easily-connected member is detachably connected with the blood collector.
6. The novel blood bag for trioxytherapy according to claim 5, wherein a blocking device is arranged in the blood sampling pipeline.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202223016023.0U CN219208433U (en) | 2022-11-14 | 2022-11-14 | Novel blood bag for trioxytherapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202223016023.0U CN219208433U (en) | 2022-11-14 | 2022-11-14 | Novel blood bag for trioxytherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN219208433U true CN219208433U (en) | 2023-06-20 |
Family
ID=86739410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202223016023.0U Active CN219208433U (en) | 2022-11-14 | 2022-11-14 | Novel blood bag for trioxytherapy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN219208433U (en) |
-
2022
- 2022-11-14 CN CN202223016023.0U patent/CN219208433U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4016879A (en) | Multi-mode cannulating apparatus | |
| KR101424934B1 (en) | Branch tube for injection set | |
| CN219208433U (en) | Novel blood bag for trioxytherapy | |
| CN102188761A (en) | Positive-pressure pinch valve | |
| CN205054871U (en) | Flushing device capable of flushing infusion bag and infusion pipeline | |
| CN109550114A (en) | A kind of reverse syringe of combination | |
| CN215018611U (en) | Thyroid gland puncture treatment device | |
| CN214550438U (en) | Simple closed thoracic drainage device | |
| JPH01151463A (en) | Appliance for injecting mixed fluid | |
| CN209809191U (en) | Pump-matching connecting pipe for electronic infusion pump | |
| CN215537361U (en) | High-pressure contrast agent injection device | |
| CN215534225U (en) | Disposable bronchofiberscope alveolar lavage liquid injection device | |
| CN217339741U (en) | Drainage tube | |
| CN217612301U (en) | From exhaust syringe needle of taking | |
| CN213076576U (en) | Transfusion soft bag | |
| CN210813109U (en) | Improved injection pump | |
| CN213642566U (en) | Single-path multi-cavity integrated indwelling needle | |
| CN221105962U (en) | Needle for puncture of joint cavity | |
| CN217828610U (en) | Novel uterine cavity perfusion tube | |
| CN217772902U (en) | Filter body, filter type syringe injection structure and drip injection structure | |
| CN213724042U (en) | Transfusion system | |
| CN219501780U (en) | Anesthetic catheter with medicine taking device | |
| CN214971030U (en) | Novel glycerine enema injection device | |
| CN219208435U (en) | Flushing pipe device for medicine changing during transfusion | |
| CN219001185U (en) | Safe cell preparation reinfusion bag |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |